CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing financial support from public and private sources for life science research
4.1.2. High prevalence of target diseases
4.1.3. Increasing R&D expenditure by pharmaceutical and biotechnology companies
4.2. Market Restraints & Challenges
4.2.1. Availability of alternative technologies for protein/nucleic acid quantification and
analysis
4.2.2. Lack of skilled professionals
4.2.3. Durability and sensitivity of transfer membranes
4.3. Market Opportunities
4.3.1. Increasing R&D activities in the field of proteomics
4.3.2. Emerging markets
CHAPTER 5. GLOBAL TRANSFER MEMBRANE MARKET – BY TYPE
5.1. PVDF (Polyvinylidene Difluoride) Transfer Membrane
5.2. Nylon Transfer Membrane
5.3. Nitrocellulose Transfer Membrane
CHAPTER 6. GLOBAL TRANSFER MEMBRANE MARKET – BY TRANSFER
METHOD
6.1. Tank Electrotransfer
6.2. Semi-Dry Electrotransfer
6.3. Dry Electrotransfer
6.4. Others
CHAPTER 7. GLOBAL TRANSFER MEMBRANE MARKET – BY APPLICATION
7.1. Northern Blotting
7.2. Southern Blotting
7.3. Western Blotting
7.4. Protein Sequencing and Amino Acid Analysis
7.5. Others
CHAPTER 8. GLOBAL TRANSFER MEMBRANE MARKET – BY END USER
8.1. Academic & Research Institutes
8.2. Pharmaceutical & Biotechnology Companies
8.3. Diagnostic Laboratories
8.4. Others
CHAPTER 9. GLOBAL TRANSFER MEMBRANE MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL TRANSFER MEMBRANE MARKET - COMPANY
PROFILES
10.1. GE Healthcare
10.2. Thermo Fisher Scientific
10.3. Merck KGaA
10.4. PerkinElmer, Inc.
10.5. Bio-Rad Laboratories, Inc.
10.6. Abcam PLC
10.7. Azure Biosystems, Inc.
10.8. Carl Roth GmbH & Co. Kg
10.9. Advansta, Inc.
10.10. Lonza Group
10.11. Axiva Sichem Biotech
10.12. Macherey-Nagel GmbH & Co. Kg
10.13. Pall Corporation
10.14. Santa Cruz Biotechnology, Inc.
10.15. ATTO Corporation
CHAPTER 11. GLOBAL TRANSFER MEMBRANE MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
